Mai Chun Wai
(International Medical University, 2014)
Toll-like receptor 4 (TLR-4) is recognised for its role in host innate immunity. Studies on TLR-4 over-activation had linked it to cancer survival and progression. Nevertheless, there is no TLR-4 inhibitor available for ...